Here’s How Much You Need Invested to Collect $1,000 a Month in Dividends
Collecting $1,000 a month in dividends sounds simple until you realize the capital required shifts every time prices move, and choosing the wrong yield can leave you exposed to a dividend cut when you can least afford it.
Every income investor eventually asks the same question: what does $1,000 a month in dividends actually cost to buy? The answer is the annual target ($12,000) divided by the yield, so it moves as prices move. That is why a sector-diversified roster matters more than a single fat yield. Realty Income (NYSE:O | O Price Prediction), the roster’s anchor, currently yields 5.04% and pays monthly, and its $0.271 per share monthly rate flows straight into a retiree’s account without waiting on a quarterly cycle. The five names below all pass a coverage screen first; the income math comes second.
Realty Income (O): Monthly Dividend Anchor
Realty Income trades at $61.25 with a 5.04% yield and an annualized forward dividend of $3.252 per share. The distribution is paid monthly, which is the entire reason this name headlines the roster.
Q2 2026 AFFO per share was $1.09 (up 3.8% year over year) against $0.8115 in monthly dividends paid during the quarter. Management raised full-year AFFO guidance to $4.44 to $4.45, portfolio occupancy sits at 98.8%, and Fitch rates the company A with Stable Outlook. The dividend track record includes 670 consecutive monthly dividends declared and 115 consecutive quarterly increases.
The bull case for an income buyer: reliable monthly cash, investment-grade balance sheet, and a growth pipeline that now includes a $6 billion hyperscale data center joint venture. The caveat: Net Debt/EBITDAre rose to 5.4x from 5.2x, and REIT valuations remain sensitive to interest rates.
Verizon Communications (VZ): Telecom Cash Machine
Verizon Communications (NYSE:VZ) closed at $50.14 and pays a quarterly dividend of $0.7075 per share, or $2.83 annualized. That is a high-yield telecom paycheck backed by one of the largest free cash flow bases in US equities.
Q2 2026 free cash flow was $6.426 billion, up 27.12% year over year, and full-year FCF guidance was raised to $21.94 to $22.14 billion. Adjusted EPS came in at $1.30, beating the $1.27 consensus, and 2026 adjusted EPS guidance was lifted to $4.99 to $5.04. CFO Tony Skiadas told investors “The dividend is still ironclad for us, and we raised the dividend”, adding that the January raise marked the 20th consecutive year of dividend increases.
The bull case: fiber growth (broadband connections reached roughly 17.1 million, up 34.5% year over year), 6% to 7% EPS growth, and a management team publicly protecting the payout. The caveat: total unsecured debt of $136.5 billion and net leverage that ticked up to 2.5x from 2.2x after the Frontier deal.
Enterprise Products Partners (EPD): Midstream Coverage King
Enterprise Products Partners (NYSE:EPD) trades at $38.94 and just raised its distribution to $0.56 per common unit quarterly, or $2.24 annualized, a 2.8% year-over-year increase. This is a fee-based midstream operator with unusually thick distribution coverage.
Q2 2026 operational distributable cash flow of $2.3 billion provided 1.9 times coverage of the cash distribution. Adjusted EBITDA hit a record $2.83 billion, up 17% year over year, on record pipeline volumes of 14.7 MMBPD. The recent quarterly progression from $0.545 to $0.55 to $0.56 confirms a still-active increase cadence, and management is executing on a $6.5 billion pipeline of growth projects under construction.
The bull case for income: 1.9x coverage is one of the highest in midstream, buybacks add optionality ($5.0 billion authorization, 34% utilized), and the LPG export terminal expansion comes online by year-end 2026. One caveat: EPD is a partnership that issues a K-1 rather than a 1099-DIV, which complicates taxes and generally makes it a poor fit for IRAs.
Altria Group (MO): Tobacco Cash Cow
Altria Group (NYSE:MO) closed at $68.88 and just declared a new quarterly dividend of $1.11 per share, taking the annualized forward dividend to $4.44. That is one of the largest cash yields in the S&P 500.
Coverage rests on a pricing-power model. 2026 adjusted diluted EPS guidance is $5.56 to $5.72, comfortably above the payout, and Q1 2026 adjusted EPS of $1.32 beat the $1.25 consensus. Altria returned $8 billion to shareholders in 2025 through dividends and buybacks combined and announced its 60th dividend increase in 56 years. Smokeable segment adjusted operating income rose 6.3% to $2.68 billion with a 65.1% margin.
The bull case: enormous, predictable cash generation and a management team that treats the dividend as sacrosanct. The caveat is real: domestic cigarette volumes declined roughly 10% in 2025, Marlboro’s retail share is slipping, and stockholders’ equity is negative $3.211 billion from years of buybacks. Volume decline is the secular headwind pricing must keep outrunning.
Bristol Myers Squibb (BMY): Pharma Payer With a 94-Year Streak
Bristol Myers Squibb (NYSE:BMY) trades at $66.83 with a quarterly dividend of $0.63 per share, or $2.52 annualized. The most recent hike marked the 17th consecutive annual dividend increase and the 94th consecutive year of dividend payments.
Payout coverage here is the strongest of the group. 2026 non-GAAP EPS guidance is $6.05 to $6.35 against the $2.52 payout, and management said results are trending toward the upper end of the range. Q1 2026 revenue was $11.49 billion, up 3%, and the Growth Portfolio grew 12% to $6.23 billion, led by Eliquis at $4.14 billion (+16%) and Camzyos at $314 million (+97%). CFO David Elkins said the company will keep “returning cash to shareholders through our commitment to the dividend”.
The bull case: a growth portfolio offsetting legacy erosion, roughly $5 billion in share buyback authorization remaining, and a payout ratio near 40% of non-GAAP EPS. The caveat: the Legacy Portfolio (Revlimid, Pomalyst, Sprycel, Abraxane) is expected to decline 12% to 16% in 2026, and net debt sits near $33.6 billion.
Putting the $1,000 a Month Together
The capital required to collect $1,000 a month falls as yields rise and rises when prices climb, so treat any capital figure as a snapshot rather than a fixed sticker. Spreading a target income across a REIT, a telecom, a midstream partnership, a tobacco payer, and a pharma diversifies the cycle risk that sinks single-industry income plans. Every one of these dividends is currently covered by cash flow or earnings, with management commentary reinforcing the payout, though dividends are never guaranteed and can be reduced. Anchoring the roster with Realty Income’s monthly schedule smooths the quarterly cadence of the other four, which is exactly what a $1,000-a-month plan is supposed to do.
Contact [email protected] for any questions or corrections.
Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.
